204
Views
21
CrossRef citations to date
0
Altmetric
Original Research

Lipid-based liquid crystalline nanoparticles as oral drug delivery vehicles for poorly water-soluble drugs: cellular interaction and in vivo absorption

, , , , , , , , , , & show all
Pages 3703-3718 | Published online: 13 Jul 2012

References

  • GursoyRNBenitaSSelf-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugsBiomed Pharmacother20045817318215082340
  • VarmaMVPanchagnulaREnhanced oral paclitaxel absorption with vitamin E-TPGS: effect on solubility and permeability in vitro, in situ and in vivoEur J Pharm Sci20052544545315890503
  • MalingréMMMeerum TerwogtJMBeijnenJHPhase I and pharmacokinetic study of oral paclitaxelJ Clin Oncol2000182468247510856107
  • GelderblomHVerweijJNooterKSparreboomACremophorELthe drawbacks and advantages of vehicle selection for drug formulationEur J Cancer2001371590159811527683
  • YangSGursoyRNLambertGBenitaSEnhanced oral absorption of paclitaxel in a novel self-microemulsifying drug delivery system with or without concomitant use of P-glycoprotein inhibitorsPharm Res20042126127015032307
  • MaXWangHJinSWuYLiangXJConstruction of paclitaxel-loaded poly (2-hydroxyethyl methacrylate)-g-poly (lactide)-1,2-dipalmitoylsn- glycero-3-phosphoethanolamine copolymer nanoparticle delivery system and evaluation of its anticancer activityInt J Nanomedicine201271313132822419875
  • YangDVanSJiangXYuLNovel free paclitaxel-loaded poly(L-γ-glutamylglutamine)-paclitaxel nanoparticlesInt J Nanomedicine20116859121289985
  • RogerELagarceFGarcionEBenoitJPLipid nanocarriers improve paclitaxel transport throughout human intestinal epithelial cells by using vesicle-mediated transcytosisJ Control Release200914017418119699246
  • LeeSCKimCKwonICChungHJeongSYPolymeric micelles of poly(2-ethyl-2-oxazoline)-block-poly(ɛ-caprolactone) copolymer as a carrier for paclitaxelJ Control Release20038943744612737846
  • YaghmurAMichaelRLiquid crystalline nanoparticles as drug nanocarriers Available at: http://www.ibr.oeaw.ac.at/people/Michael/Rappolt_Publ-Dateien/MR2010_5.pdfAccessed May 31, 2012
  • YangDArmitageBMarderSRMinireviews cubic liquid-crystalline nanoparticlesAngew Chem Int Ed Engl2004434402440915317018
  • YaghmurAGlatterOCharacterization and potential applications of nanostructured aqueous dispersionsAdv Colloid Interface Sci2009147–148333342
  • EfratRAserinAKesselmanEDaninoDWachtelEGartiNLiquid micellar discontinuous cubic mesophase from ternary monoolein/ethanol/water mixturesColloids Surf A Physiochem Eng Asp2007299133145
  • LeeKWYNguyenTHHanleyTBoydBJNanostructure of liquid crystalline matrix determines in vitro sustained release and in vivo oral absorption kinetics for hydrophilic model drugsInt J Pharm200936519019918790030
  • KaasgaardTDrummondCJOrdered 2-D and 3-D nanostructured amphiphile self-assembly materials stable in excess solventPhys Chem Chem Phys200684957497517091149
  • RosenbaumETavelinSJohanssonLBA characterisation study on the application of inverted lyotropic phases for subcutaneous drug releaseInt J Pharm2010388525720026201
  • CervinCVandoolaeghePNistorCTibergFJohnssonMA combined in vitro and in vivo study on the interactions between somatostatin and lipid-based liquid crystalline drug carriers and bilayersEur J Pharm Sci20093637738519041716
  • JohnssonMBarauskasJNorlinATibergFPhysicochemical and drug delivery aspects of lipid-based liquid crystalline nanoparticles: a case study of intravenously administered propofolJ Nanosci Nanotechnol200663017302417048513
  • RizwanSBAssmusDBoehnkeAPreparation of phytantriol cubosomes by solvent precursor dilution for the delivery of protein vaccinesEur J Pharm Biopharm201179152221237267
  • LaiJChenJLuYGlyceryl monooleate/poloxamer 407 cubic nanoparticles as oral drug delivery systems: I. in vitro evaluation and enhanced oral bioavailability of the poorly water-soluble drug simvastatinAAPS Pharm Sci Tech200910960966
  • BatrakovaEVLiSVinogradovSVAlakhovVYMillerDWKabanovAVMechanism of Pluronic effect on P-glycoprotein efflux system in blood-brain barrier: contributions of energy depletion and membrane fluidizationJ Pharmacol Exp Ther20019948349311602658
  • GaoXWangTWuBQuantum dots for tracking cellular transport of lectin-functionalized nanoparticlesBiochem Biophys Res Commun2008377354018823949
  • RizwanSBDongYDBoydBJRadesTHookSCharacterisation of bicontinuous cubic liquid crystalline systems of phytantriol and water using cryo field emission scanning electron microscopy (cryo-FESEM)Micron20073847848517011783
  • BarauskasJCervinCJankunecMInteractions of lipid-based liquid crystalline nanoparticles with model and cell membranesInt J Pharm201039128429120214966
  • AngelovaAAngelovBMutafchievaRLesieurSCouvreurPSelf-assembled multicompartment liquid crystalline lipid carriers for protein, peptide, and nucleic acid drug deliveryAcc Chem Res20114414715621189042
  • SiekmannBBunjesHKochMHJWestesenKPreparation and structural investigations of colloidal dispersions prepared from cubic monoglyceride-water phasesInt J Pharm2002244334312204563
  • BoydBJKhooSMWhittakerDVDaveyGPorterCJHA lipid-based liquid crystalline matrix that provides sustained release and enhanced oral bioavailability for a model poorly water soluble drug in ratsInt J Pharm2007340526017467935
  • BoydBJControlled release from cubic liquid-crystalline particles (cubosomes)LynchMLSpicerPTBicontinuous Liquid CrystalsBoca Raton, FLCRC Press Inc2005
  • BoydBJCharacterisation of drug release from cubosomes using the pressure ultrafiltration methodInt J Pharm200326023924712842343
  • GargGSarafSSarafSCubosomes: an overviewBiol Pharm Bull20073035035317268078
  • ShenHCrowstonJGHuberFSaubernSMcLeanKMHartleyPGThe influence of dipalmitoyl phosphatidylserine on phase behaviour of and cellular response to lyotropic liquid crystalline dispersionsBiomaterials2010319473948120880581
  • TenchovBGMacDonaldRCSiegelDPCubic phases in phosphatidylcholine-cholesterol mixtures: cholesterol as membrane “fusogen”Biophys J2006912508251616829556
  • GreenspanPMayerEPFowlerSDNile red: a selective fluorescent stain for intracellular lipid dropletsJ Cell Biol1985109659733972906
  • XiaoLXiongXXiongXRole of cellular uptake in the reversal of multidrug resistance by PEG-b-PLA polymeric micellesBiomaterials2011325148515721546083
  • LamprechtABenoitJPEtoposide nanocarriers suppress glioma cell growth by intracellular drug delivery and simultaneous P-glycoprotein inhibitionJ Control Release200611220821316574265
  • RogerELagarceFGarcionEBenoitJPReciprocal competition between lipid nanocapsules and P-gp for paclitaxel transport across Caco-2 cellsEur J Pharm Sci20104042242920438839
  • XuPGullottiETongLIntracellular drug delivery by poly (lactic-co-glycolic acid) nanoparticlesMol Pharm2009619020119035785
  • JacobsonKMouritsenOGAndersonRGWLipid rafts: at a crossroad between cell biology and physicsNat Cell Biol2007971417199125
  • OrlandiPAFishmanPHFilipin-dependent inhibition of cholera toxin: evidence for toxin internalization and activation through caveolae-like domainsJ Cell Biol19981419059159585410
  • GarmannDWarneckeAKalaydaGVKratzFJaehdeUCellular accumulation and cytotoxicity of macromolecular platinum complexes in cisplatin-resistant tumor cellsJ Control Release200813110010618691617
  • ChiuYLHoYCChenYMThe characteristics, cellular uptake and intracellular trafficking of nanoparticles made of hydrophobically-modified chitosanJ Control Release201014615215920580915
  • XiaoLXiongXXiongXRole of cellular uptake in the reversal of multidrug resistance by PEG-b-PLA polymeric micellesBiomaterials2011325148515721546083